Qlife: Fully secures ongoing rights issue with top guarantee commitments
Qlife fully secures ongoing rights issue with top guarantee commitments. The top guarantee syndicate amounts to approximately SEK 16.6 million, which corresponds to approximately 28.7 percent of the Rights Issue. Consequently, the Rights Issue is secured to 100 percent through the previously announced subscription undertakings and guarantee commitments and the top guarantee syndicate
Further information about who/whom are the top guarantees will be published as soon as the Swedish Financial Supervisory Authority has approved the new prospectus.
Read more: https://qlifeholding.com/en/news/qlife-fully-secures-ongoing-rights-issue-top-guarantee-commitments
Read about the rights issue here: https://qlifeholding.com/en/news/qlife-publishes-prospectus-due-upcoming-rights-issue-units
Disclaimer: HC Andersen Capital receives payment from Qlife for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 5:40 PM 04-17-2023.
Qlife Holding
Qlife Holding AB er et medico teknisk selskab, der stræber efter at revolutionere markedet for kliniske biomarkør- og virustest. Ved at muliggøre test derhjemme som et supplement til test i sundhedssystemet, lettes adgang til vigtige sundhedsinformationer, hvilket kan bidrage til bedre behandling og potentielt forebygge sygdomme. De første testkapsler i virksomhedens brand, Egoo. Health Platform, blev CE-mærket til professionelt brug i begyndelsen af 2020. Virksomheden har patentbeskyttelse for centrale dele af sin teknologi. Det danske selskab er noteret på Nasdaq First North Stockholm.
Read more on company page